These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9333499)

  • 1. [The clinical efficacy of tanakan in patients with stage-I atherosclerotic circulatory encephalopathy].
    Rudenko AE; Lushchik UB; Dzhumik VA
    Lik Sprava; 1997; (2):99-101. PubMed ID: 9333499
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new approach to the treatment of patients with circulatory encephalopathy].
    Kupnovyts'ka MIu; Lushchyk UB; Herasymchuk RD; Chmyr HS; Iatsyshyn RI; Dubanovych LB
    Lik Sprava; 1997; (5):142-5. PubMed ID: 9491724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Collagen-induced thrombocyte aggregation in parenteral therapy using Ginkgo biloba].
    Költringer P; Eber O
    Wien Med Wochenschr; 1989 Mar; 139(5):92-4. PubMed ID: 2658335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
    Kuznetsova SM; Glazovskaia II; Kuznetsov VV
    Lik Sprava; 1997; (6):132-4. PubMed ID: 9589957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Bachinskaia NIu; Kochubeĭ NV
    Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tanakan in the treatment of perinatal injuries of the central nervous system].
    Shprakh VV; Saiutina SB; Revezova TV; Pak KO; Arbatskaia OIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(3):33-5. PubMed ID: 10758645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary investigation of Tanakan in the treatment of hypertensive arteriosclerosis and stroke in rats.
    Fang Y; Huang R; Zhang Y; Lin J; Li J
    Chin Med J (Engl); 2000 May; 113(5):425-8. PubMed ID: 11776097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tanakan in the treatment of primary manifestations of insufficiency of brain blood supply].
    Timerbaeva SL; Suslina ZA; Bodareva EA; Fedin PA; Korepina OS; Pervosvanskiĭ BE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):24-8. PubMed ID: 10983363
    [No Abstract]   [Full Text] [Related]  

  • 10. [The results of using different forms of a Ginkgo biloba extract (EGb 761) in the combined treatment of patients with circulatory encephalopathy].
    Ivaniv OP
    Lik Sprava; 1998 Dec; (8):123-8. PubMed ID: 10204370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of tanakan on blood lipid peroxidation and platelet aggregation properties in patients with insulin-dependent diabetes mellitus].
    Balashova TS; Kubatiev AA
    Ter Arkh; 1998; 70(12):49-54. PubMed ID: 10067254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases].
    Montanini R; Gaspari G
    Minerva Cardioangiol; 1969 Dec; 17(12):1096-102. PubMed ID: 5373481
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ginkgo biloba flavone glycoside. Therapeutic possibilities for cerebral insufficiency].
    Haan J; Reckermann U; Welter FL; Sabin G; Müller E
    Med Welt; 1982 Jul; 33(27):1001-5. PubMed ID: 7144495
    [No Abstract]   [Full Text] [Related]  

  • 14. [The drug correction of disorders in the erythrocyte structural-functional properties of patients with atherosclerotic circulatory encephalopathy].
    Voloshin PV; Iavorskaia VA; Malakhov VA
    Vrach Delo; 1991 Apr; (4):59-62. PubMed ID: 2063570
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
    Schweizer J; Hautmann C
    Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Ginkgo biloba extract in arterial occlusive disease. Randomized placebo controlled crossover study].
    Rudofsky G
    Fortschr Med; 1987 Jul; 105(20):397-400. PubMed ID: 3301603
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term treatment of circulatory disturbances of the retina and optic (author's transl)].
    Merté HJ; Merkle W
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):577-83. PubMed ID: 7253510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary degenerative dementia: therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study].
    Weitbrecht WU; Jansen W
    Fortschr Med; 1986 Mar; 104(9):199-202. PubMed ID: 3516818
    [No Abstract]   [Full Text] [Related]  

  • 19. [The efficacy of treatment with the tranquilizer tranxene in elderly persons with psychoemotional disorders against a background of initial and moderately pronounced atherosclerotic circulatory encephalopathy].
    Grebel'nik VI
    Lik Sprava; 1995; (7-8):29-32. PubMed ID: 8846366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of treating cerebral ischemia due to changes in the major cerebral arteries by using the preparation Tanakan (EGB 761)].
    Dziak LA; Golik VA
    Lik Sprava; 1998 Aug; (6):125-7. PubMed ID: 9844896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.